Citadel Advisors »

Entero Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Entero Therapeutics (GRDX) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Entero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entero Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entero Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $400k 85k 4.69

More positions owned by Citadel Advisors

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Micron Technology Call Option (MU)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Sandisk Corp (SNDK)
Advanced Micro Devices Call Option (AMD)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Meta Platforms Cl A (META)
Ishares Tr Core S&p500 Etf (IVV)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Amazon (AMZN)

View all positions for Citadel Advisors

Top funds holding Entero Therapeutics

Renaissance Technologies
Citadel Advisors
Federation des caisses Desjardins du Quebec
Vanguard Capital Management
Geode Capital Management
Jane Street
Vanguard Fiduciary Trust
State Street Corporation
Hrt Financial
Independent Advisor Alliance
Northern Trust
Harbour Investments
Jones Financial Companies, L.L
Tower Research Capital
Barclays

View all funds holding Entero Therapeutics